Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Martin Finkelstein
Intestinal Toxicity in Rats Following Administration of Cdk4/6 Inhibitors Is Independent of Primary Pharmacology
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Treating ER+ Breast Cancer With CDK4/6 Inhibitors
Cancer Discovery
Oncology
CDK4/6 Inhibitors: Promising Opportunities Beyond Breast Cancer
Cancer Discovery
Oncology
Loss of FAT1 Drives Resistance to CDK4/6 Inhibitors in Breast Cancer
Cancer Discovery
Oncology
CDK4/6 Inhibitors resTORe Therapeutic Sensitivity in HER2 + Breast Cancer
Cancer Cell
Cancer Research
Oncology
Cell Biology
Inhibitors Targeting CDK4/6, PARP and PI3K in Breast Cancer: A Review
Therapeutic Advances in Medical Oncology
Oncology
A Novel Tankyrase Inhibitor, MSC2504877, Enhances the Effects of Clinical CDK4/6 Inhibitors
Scientific Reports
Multidisciplinary
Effects Following the Intestinal Administration of (Iletin) Insulin
American Journal of Physiology-Legacy Content
Cdk4/6 Inhibitors and Overall Survival: Power of First-Line Trials in Metastatic Breast Cancer
npj Breast Cancer
Oncology
Radiology
Nuclear Medicine
Pharmacology
Imaging
Chemoproteomics Reveals Novel Protein and Lipid Kinase Targets of Clinical CDK4/6 Inhibitors in Lung Cancer
ACS Chemical Biology
Biochemistry
Medicine
Molecular Medicine